Presspart to exhibit at Drug Delivery to the Lung Conference 2013 (DDL24)
Presspart, the world’s leading provider of metered-dose inhaler components, has once again confirmed their attendance as an exhibitor at the upcoming Drug Delivery to the Lungs Conference (DDL24) 2013 in Edinburgh, Scotland, on the 11-13 December.
Presspart’s stand will be located in the Moffat area which is located outside the main exhibition centre which this year is being held in the Lennox suite, which is part of the newly built extension at the Edinburgh International Conference Centre (EICC).
As in previous year’s Presspart will be exhibiting its full range of pharmaceutical components for respiratory drug delivery including metered-dose inhaler canisters, metered-dose inhaler actuators as well as pharmaceutical dispensing actuators for oral, topical and aural use.
Presspart will also be taking the opportunity at DDL24 to promote its Inhalation Product Technology Centre (IPTC) which was launched earlier in the year. Visitors will have the opportunity to learn more about this industry first IPTC and what its capabilities and functions are and how it will benefit the customers of Presspart
Following on from the success of last years exhibition, Presspart will again have on the stand a little game for exhibitors to have a go on and hopefully win a prize.
Over the three days, as well as the exhibition, the DDL conference will include a number of workshops focusing on a variety of topics within drug delivery to the lungs. There will also be the scientific posters for viewing, as well as plenty of opportunities to network at what is the last major exhibition for the industry before the holiday season.
DDL will run from 11-13 December at the Edinburgh International Conference Centre, with Presspart’s stand being located in the Moffat suite.